meQuilibrium provides a scientific, data-driven, highly personalized digital resilience platform designed to prevent burnout and mitigate behavioral health risks while improving performance and retention. Its core product delivers personalized curricula and interventions that drive strong employee engagement compared with reactive employee assistance programs. With new capital, the company plans to expedite its product roadmap, pursue acquisitions of complementary technologies, and launch expanded go-to-market initiatives. Vistara Growth's investment will also support hiring to meet increasing demand from larger customers, including more Fortune 500 companies. meQuilibrium has recorded a three-year revenue CAGR of more than 50% and reported a customer NPS of 73 (June 2021). The company has been recognized on multiple industry lists, including the Financial Times 2021 Fastest Growing Companies, the Inc. 5000 (2019–2021), Deloitte Fast 500, SaaS Award Best Product in HR 2021, and MassTLC Tech Top 50. meQuilibrium delivers an engagement and performance platform that uses clinically-validated assessments, predictive meQ scores and data-driven insights to measure resilience and create personalized training programs. The product combines behavioral psychology and neuroscience to build employee and team skills that increase agility, adaptive capacity and performance. The company is expanding its platform across the human capital management (HCM) category, developing a next‑generation cognitive solution to add talent optimization, soft-skill and upskill development. The expanded platform is intended to leverage existing people analytics and enable frictionless integration and data sharing with talent, benefits, engagement and LMS vendors. meQuilibrium serves global Fortune 500 companies and has doubled its growth two years in a row. Recent leadership hires include a new SVP of Product Strategy and an SVP of Customer Success to support product and customer expansion. meQuilibrium offers an individualized, online stress-management and resilience-building program delivered as a SaaS platform for mobile and desktop. The product begins with a personalized assessment and guides users through a long-term roadmap focused on skills to boost resilience. Its approach is based on research at the University of Pennsylvania and the platform aggregates crowd intelligence to generate workforce well-being metrics and insights. The service is currently used by large employers including Comcast, HP, Grant Thornton, Nemours and Meredith. Led by CEO Jan Bruce, the company plans to accelerate sales and marketing and expand product development with the new funding. meQuilibrium is an online lifestyle management platform that provides a personalized experience for individuals to uncover, assess, and manage the stresses in their lives. The product will launch with a free stress tracker app and a paid service with tools and exercises to assess and improve resilience to stress based on a personalized stress profile and an individual “meQ” score. The company was founded by CEO Jan Bruce and is based in Boston, MA. It closed a $2.3M Series A financing to commercialize the product and accelerate national sales efforts. Chrysalis Principal Wright Steenrod joined the company’s board in conjunction with the funding. The company intends to use the funds to commercialize its product and accelerate national sales efforts.

Total raised

$18M

Funding rounds

4

Latest round

Series C

Latest activity

Aug 2018